[
The Select Drug Program Formulary is a list of medications approved by the 
U.S. Food and Drug Administration that
were chosen for formulary coverage based on their medical effectiveness, 
safety, and value. The list changes periodically
as the Pharmacy and Therapeutics Committee reviews the formulary to ensure its 
continued effectiveness. The most
recent changes are listed below.
Reminder about the Preventive 
Medication Program included in our prescription drug plan
Certain preventive medications, as described in the 
Patient Protection and Affordable Care Act (PPACA),
including generic products and those brand products that do not have a generic 
equivalent, are covered without cost-sharing with a doctor?s prescription when 
provided by a participating retail or mail-order pharmacy. Coverage includes 
certain products within the following drug categories: (1) aspirin to prevent 
cardiovascular disease for men age 45-79 and women age 55-79, (2) breast cancer 
chemotherapy prevention for women, (3) fluoride supplementation for children 6 
months through 6 years, (4) folic acid supplementation for women planning or 
capable of pregnancy, (5) iron supplementation for children ages 6
to 12 months who are at increased risk for iron deficiency anemia, (6) tobacco 
interventions for adults who use tobacco products, and (7) vitamin D 
supplementation for ages 65 and over to prevent falls.
Contraceptives, mandated by the Women?s Preventive 
Services provision of the PPACA, are covered at 100 percent when provided by a 
participating provider for generic products and for those brand products that 
do not have a generic equivalent. Brand contraceptive products with a generic 
equivalent are covered at the brand cost-sharing level for the member?s 
plan.
Generic additions
These generic drugs recently became available in the marketplace. When these 
generic drugs became available, we began covering them at the appropriate 
generic formulary level of cost-sharing:
Generic drug
	Brand drug
		Formulary chapter
			Effective date
acitretin
	Soriatane?
		  5. Skin Medications
			July 25, 2013
alendronate sodium solution
	Fosamax? solution
		10. Female, Hormone Replacement, &
		Birth Control
			April 26, 2013
candesartan cilexetil
	 Atacand? 
		4. Heart, Blood Pressure, & Cholesterol
			May 23, 2013
chorionic gonadotropin
	 Novarel?/Pregnyl?
		15. Diagnostics & Miscellaneous
			January 1, 2014
dihydrocodeine/aspirin/caffeine
	Synalgos?-DC
		3. Pain, Nervous System, & Psych
			May 31, 2013
fenofibric acid (choline) 
	Trilipix?
		 4. Heart, Blood Pressure, & Cholesterol
			July 19, 2013
metronidazole topical gel
	Metrogel?
		5. Skin Medications
			July 3, 2013
omeprazole suspension
	First?-Omeprazole
		8. Stomach, Ulcer, & Bowel Meds
			June 28, 2013
quazepam
	 Doral?
		3. Pain, Nervous System, & Psych
			July 12, 2013
repaglinide 
	Prandin?
		7. Diabetes, Thyroid, Steroids, & Other
		Miscellaneous Hormones
			July 25, 2013
riluzole
	Rilutek?
		3. Pain, Nervous System, & Psych
			June 7, 2013
zolmitriptan
	Zomig?, Zomig-ZMT?
		3. Pain, Nervous System, & Psych
			May 17, 2013
			
			Brand additions
			These brand drugs were added to the formulary as of the dates indicated 
below and are covered at the appropriate
			brand formulary level of cost-sharing:
			
Brand drug
	Formulary chapter
		Effective date
Advate?
	15. Diagnostics & Miscellaneous
		January 1, 2014
Alphanate?
	15. Diagnostics & Miscellaneous
		January 1, 2014
Alphanine? SD
	15. Diagnostics & Miscellaneous
		January 1, 2014
Bebulin?
	15. Diagnostics & Miscellaneous
		January 1, 2014
BeneFIX?
	15. Diagnostics & Miscellaneous
		January 1, 2014
Cialis?
	13. Urinary & Prostate Meds
		October 1, 2013
Feiba NF?
	15. Diagnostics & Miscellaneous
		January 1, 2014
Helixate? FS
	15. Diagnostics & Miscellaneous
		January 1, 2014
Hemofil? M
	15. Diagnostics & Miscellaneous
		January 1, 2014
Humate-P?
	15. Diagnostics & Miscellaneous
		January 1, 2014
Koate?-DVI
	15. Diagnostics & Miscellaneous
		January 1, 2014
Kogenate? FS
	15. Diagnostics & Miscellaneous
		January 1, 2014
Lialda?
	3. Pain, Nervous System, & Psych
		November 1, 2013
LiptruzetTM
	4. Heart, Blood Pressure, & Cholesterol
		November 1, 2013
Monoclate-P?
	15. Diagnostics & Miscellaneous
		January 1, 2014
Mononine?
	15. Diagnostics & Miscellaneous
		January 1, 2014
NovoSeven? RT
	15. Diagnostics & Miscellaneous
		January 1, 2014
Profilnine? SD
	15. Diagnostics & Miscellaneous
		January 1, 2014
RecombinateTM
	15. Diagnostics & Miscellaneous
		January 1, 2014
Vascepa?
	4. Heart, Blood Pressure, & Cholesterol
		November 1, 2013
Wilate?
	15. Diagnostics & Miscellaneous
		January 1, 2014
Xarelto?
	4. Heart, Blood Pressure, & Cholesterol
		November 1, 2013
Xyntha?
	15. Diagnostics & Miscellaneous
		January 1, 2014
		
 
		 Brand deletions
		Effective January 1, 2014, these brand drugs will be covered at the 
appropriate non-formulary level of cost-sharing:
		
Brand drug
	Formulary therapeutic alternatives
		Formulary chapter
Cortef
? 5mg, 10mg
	hydrocortisone
		9. Bone, Joint, & Muscle
Efudex
?
	fluorouracil
		5. Skin Medications
Lanoxin
?
	digoxin
		4. Heart, Blood Pressure, & Cholesterol
Metrogel
?
	metronidazole topical gel
		5. Skin Medications
Prandin
?
	repaglinide
		7. Diabetes, Thyroid, Steroids, & Other
		Miscellaneous Hormones
Trilipix
?
	fenofibric acid (choline)
		4. Heart, Blood Pressure, & Cholesterol
		
The generic drugs for the above brand drugs are on our formulary and 
available at the generic formulary level of
		cost-sharing.
]